Matching slides 9,718
Current window 4,651-4,680
Pages 324
Rows per page 30
Loop: 47 Quick Win Big Betclear collectionreset all

Loop

4,651-4,680 of 9,718

filter-aware
12
The slide uses a combination of bulleted lists and representative imagery to illustrate industrial applications (logistics, shipping, aviation).Aeva | Results Presentation Deck | 17 slides · Aeva
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
17
The slide uses a mix of metrics and partner logos to validate the company's financing strategy.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
18
Utilization rate calculation note provided in footer.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
20
The slide uses a structured layout to present product benefits alongside key traction metrics.Apollo Global Management | Investor Presentation Deck | 37 slides · Apollo Global Management
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
21
The slide uses a four-column framework to explain the business model's value proposition.Apollo Global Management | Investor Presentation Deck | 37 slides · Apollo Global Management
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
22
The slide uses a five-column layout with icons to summarize the deal structure and outcomes.Apollo Global Management | Investor Presentation Deck | 37 slides · Apollo Global Management
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
23
Apollo Global Management | Investor Presentation Deck | 37 slidesApollo Global Management | Investor Presentation Deck | 37 slides · Apollo Global Management
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
26
The slide uses a simple, bold statement to define the company's scale ambition.Arrival | Results Presentation Deck | 30 slides · Arrival
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
27
The slide consists of a single paragraph of text on a black background, serving as a core value proposition statement.Arrival | Results Presentation Deck | 30 slides · Arrival
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
14
The slide outlines a strategic partnership as a solution to scale operations and meet financial targets.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
15
Includes a reconciliation of reported vs adjusted figures and specific commentary on segment performance and operational challenges.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
10
Includes waterfall plot for partial response and spider plot for longitudinal tumor change.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
11
The slide uses a process-flow diagram to map patient cohorts to clinical outcomes and subsequent study advancement decisions.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
12
Includes a spider plot for lesion change and a Kaplan-Meier survival curve.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
13
Includes Kaplan-Meier survival curve and waterfall plot for lesion change.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
14
Clinical trial data showing PFS at 3 months for Liposarcoma and Synovial Sarcoma cohorts.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
15
Includes specific clinical trial terminology (CTCAE, SAE, RP2D, Q2W).BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
16
The slide uses a grid of metrics to establish the total addressable market and clinical benchmarks.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
17
The chart is a waterfall plot showing maximum change from baseline for different patient cohorts.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
18
The slide uses a process-oriented layout to describe clinical trial phases.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
19
Clinical trial data for BA3011 in NSCLC patients.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
20
Clinical trial data presentation for oncology drug candidate.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
21
The slide serves as a section divider for a deep dive into a specific therapeutic platform.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
22
The slide uses a grid of metrics to define the total addressable market and the specific target segment.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
23
The chart is a waterfall plot showing percentage change in tumor size for individual patients.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
24
The slide uses a 2x2 grid of metrics to frame the market problem, followed by specific target population and success threshold data.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
25
The chart displays longitudinal data for two specific patients, showing sustained complete response.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
26
SCCHN = Squamous Cell Carcinoma of the Head and Neck. ROR2 is the target biomarker.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
27
The slide uses a table to present clinical outcomes for specific tumor types, emphasizing the first-in-class potential of the therapy.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
04
Slide 4 of the Cazoo pitch deck.Cazoo | Investor Presentation Deck | 16 slides · Cazoo
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit